Europe Newborn Screening Market - Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE NEWBORN SCREENING MARKET

1.4 LIMITATIONS

1.5 CURRENCY AND PRICING

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 SECONDARY SOURCES

2.7 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING PREVALENCE OF NEWBORN SCREENING

3.1.2 GROWTH IN NEONATAL DISEASES

3.1.3 INCREASED GOVERNMENT INITIATIVES

3.1.4 TECHNOLOGICAL ADVANCEMENTS IN SCREENING

3.2 RESTRAINTS

3.2.1 STRINGENT REGULATORY POLICIES

3.2.2 HIGH COST OF AUTOMATED DEVICES

3.3 OPPORTUNITIES

3.3.1 NEXT-GENERATION SEQUENCING TECHNOLOGY FOR NEWBORN SCREENING

3.3.2 EMERGING MARKET

3.4 CHALLENGES

3.4.1 SOCIO ECONOMIC BARRIERS

3.4.2 LACK OF SKILLED PROFESSIONALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE

6.1 OVERVIEW

6.2 DRIED BLOOD SPOT TEST

6.3 HEARING SCREEN TEST

6.4 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST

7 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 INSTRUMENTS

7.2.1 NEWBORN DISORDER SCREENING INSTRUMENTS

7.2.2 NEWBORN HEARING SCREENING INSTRUMENTS

7.2.3 PULSE OXIMETER

7.3 REAGENTS AND ASSAY KITS

8 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 TANDEM MASS SPECTROMETRY

8.3 HEARING SCREEN TECHNOLOGY

8.4 PULSE OXIMETRY SCREENING TECHNOLOGY

8.5 IMMUNOASSAYS AND ENZYMATIC ASSAYS

8.6 ELECTROPHORESIS

8.7 DNA-BASED ASSAYS

9 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE

9.1 OVERVIEW

9.2 CRITICAL CONGENITAL HEART DISEASES

9.3 NEWBORN HEARING LOSS

9.4 SICKLE CELL DISEASE

9.5 PHENYLKETONURIA (PKU)

9.6 CYSTIC FIBROSIS (CF)

9.7 MAPLE SYRUP URINE DISEASE

9.8 OTHERS

10 EUROPE NEWBORN SCREENING MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITAL

10.3 PEDIATRIC CLINICS

10.4 CLINICS

11 EUROPE NEWBORN SCREENING MARKET, BY GEOGRAPHY

11.1 EUROPE

11.1.1 GERMANY

11.1.2 FRANCE

11.1.3 U.K.

11.1.4 SPAIN

11.1.5 ITALY

11.1.6 SWITZERLAND

11.1.7 NETHERLANDS

11.1.8 RUSSIA

11.1.9 TURKEY

11.1.10 BELGIUM

11.1.11 REST OF EUROPE

12 EUROPE NEWBORN SCREENING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 COMPANY PROFILES

13.1 PERKINELMER INC.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 PRODUCT PORTFOLIO

13.1.4 RECENT DEVELOPMENTS

13.2 NATUS MEDICAL INCORPORATED

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 PRODUCT PORTFOLIO

13.2.4 RECENT DEVELOPMENTS

13.3 TRIVITRON HEALTHCARE

13.3.1 COMPANY SNAPSHOT

13.3.2 PRODUCT PORTFOLIO

13.3.3 RECENT DEVELOPMENTS

13.4 BAEBIES, INC.

13.4.1 COMPANY SNAPSHOT

13.4.2 PRODUCT PORTFOLIO

13.4.3 RECENT DEVELOPMENTS

13.5 BIO-RAD LABORATORIES, INC.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 PRODUCT PORTFOLIO

13.5.4 RECENT DEVELOPMENT

13.6 DANAHER

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENT

13.7 HILL-ROM SERVICES INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENT

13.8 INTELLIGENT HEARING SYSTEMS

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENT

13.9 INTERACOUSTICS A/S

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.10 MASIMO

13.10.1 COMPANY SNAPSHOT

13.10.2 REVENUE ANALYSIS

13.10.3 PRODUCT PORTFOLIO

13.10.4 RECENT DEVELOPMENT

13.11 MEDTRONIC

13.11.1 COMPANY SNAPSHOT

13.11.2 REVENUE ANALYSIS

13.11.3 PRODUCT PORTFOLIO

13.11.4 RECENT DEVELOPMENT

13.12 OTODYNAMICS LTD

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 VIVASONIC INC.

13.13.1 COMPANY SNAPSHOT

13.13.2 PRODUCT PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 ZENTECH S.A.

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S.

TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018

TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016)

TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018)

TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018)

TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION)

TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS

TABLE 9 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 10 EUROPE DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 EUROPE HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 EUROPE CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 14 EUROPE PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 EUROPE INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 16 EUROPE REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 18 EUROPE TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 EUROPE HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 EUROPE PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 EUROPE ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 25 EUROPE CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 EUROPE SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 EUROPE MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 33 EUROPE HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 EUROPE CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 37 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 38 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 39 EUROPE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 40 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 41 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 42 EUROPE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 44 GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 45 GERMANY INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 46 GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 47 GERMANY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 48 GERMANY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 49 FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 50 FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 51 FRANCE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 52 FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 53 FRANCE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 54 FRANCE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 55 U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 56 U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 57 U.K. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 58 U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 59 U.K. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 60 U.K. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 61 SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 62 SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 63 SPAIN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 64 SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 65 SPAIN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 66 SPAIN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 68 ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 69 ITALY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 70 ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 71 ITALY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 72 ITALY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 73 SWITZERLAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 74 SWITZERLAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 75 SWITZERLAND INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 76 SWITZERLAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 77 SWITZERLAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 78 SWITZERLAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 79 NETHERLANDS NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 80 NETHERLANDS NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 81 NETHERLANDS INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 82 NETHERLANDS NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 83 NETHERLANDS NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 84 NETHERLANDS NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 85 RUSSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 86 RUSSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 87 RUSSIA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 88 RUSSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 89 RUSSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 90 RUSSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 91 TURKEY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 92 TURKEY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 93 TURKEY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 94 TURKEY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 95 TURKEY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 96 TURKEY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 97 BELGIUM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)

TABLE 98 BELGIUM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 99 BELGIUM INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 100 BELGIUM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 101 BELGIUM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)

TABLE 102 BELGIUM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 103 REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)